Patients and families rely on clinicians to provide transparent and precise prognostic information to make informed, value-based choices about end-of-life care.
1-5 Studies have shown that physicians often overestimate survival or are reticent to discuss prognosis and end-of-life preferences owing to perceived patient distress, rapidly progressive science, and lack of prognostic confidence.
6-16 This overestimation may result in unwanted care and overuse of health care services near the end of life as evidenced by findings that most patients die outside the home and patient preferences are followed completely only about half of the time.
17-19 Within the oncology population, there remains high use of intensive care and chemotherapy and underuse of hospice care near the end of life, costing billions of dollars to the US health care system.
20,21 Improving prognostic confidence and facilitating alignment between patient values and therapeutic delivery represents an important value proposition for patients, caregivers, clinicians, and payers.
22